TreeWAS – Variant ID: rs4821544

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
C34.1 Upper lobe, bronchus or lung	0.064	0.936	0.000
C34 Malignant neoplasm of bronchus and lung	0.059	0.941	0.000
C34.2 Middle lobe, bronchus or lung	0.055	0.945	0.000
C34.8 Overlapping lesion of bronchus and lung	0.054	0.946	0.000
C34.0 Main bronchus	0.054	0.946	0.000
N94.1 Dyspareunia	0.000	0.950	0.050
M54.57 Low back pain (Lumbosacral region)	0.045	0.955	0.000
C34.3 Lower lobe, bronchus or lung	0.039	0.961	0.000
H81.2 Vestibular neuronitis	0.000	0.972	0.028
C83 Diffuse non-Hodgkin's lymphoma	0.027	0.973	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.027	0.973	0.000
C83.1 Small cleaved cell (diffuse)	0.027	0.973	0.000
H81 Disorders of vestibular function	0.000	0.974	0.026
H81.1 Benign paroxysmal vertigo	0.000	0.974	0.026
C83.0 Small cell (diffuse)	0.025	0.975	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.025	0.975	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.024	0.976	0.000
C81 Hodgkin's disease	0.023	0.977	0.000
H81.0 Meniere's disease	0.000	0.978	0.022
H81.9 Disorder of vestibular function, unspecified	0.000	0.978	0.022
N94 Pain and other conditions associated with female genital organs and menstrual cycle	0.000	0.978	0.022
C90.2 Plasmacytoma, extramedullary	0.022	0.978	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.021	0.979	0.000
N94.3 Premenstrual tension syndrome	0.000	0.979	0.021
C34.9 Bronchus or lung, unspecified	0.021	0.979	0.000
H81.8 Other disorders of vestibular function	0.000	0.979	0.021
C90.0 Multiple myeloma	0.021	0.979	0.000
C92 Myeloid leukaemia	0.021	0.979	0.000
C83.6 Undifferentiated (diffuse)	0.020	0.980	0.000
C83.5 Lymphoblastic (diffuse)	0.020	0.980	0.000
C83.4 Immunoblastic (diffuse)	0.020	0.980	0.000
C83.2 Mixed small and large cell (diffuse)	0.020	0.980	0.000
C86 Other specified types of T/NK-cell lymphoma	0.020	0.980	0.000
C93 Monocytic leukaemia	0.020	0.980	0.000
C88 Malignant immunoproliferative diseases	0.020	0.980	0.000
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.020	0.980	0.000
H81.4 Vertigo of central origin	0.000	0.981	0.019
C81.0 Lymphocytic predominance	0.019	0.981	0.000
N94.5 Secondary dysmenorrhoea	0.000	0.981	0.019
C81.1 Nodular sclerosis	0.018	0.981	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.018	0.982	0.000
C81.2 Mixed cellularity	0.018	0.982	0.000
C83.7 Burkitt's tumour	0.018	0.982	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.018	0.982	0.000
C94 Other leukaemias of specified cell type	0.018	0.982	0.000
C92.1 Chronic myeloid leukaemia	0.018	0.982	0.000
H81.3 Other peripheral vertigo	0.000	0.982	0.018
C90.3 Solitary plasmacytoma	0.017	0.982	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.017	0.982	0.000
C90.1 Plasma cell leukaemia	0.017	0.983	0.000
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction	0.000	0.983	0.017
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.017	0.983	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.017	0.983	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.017	0.983	0.000
C45.9 Mesothelioma, unspecified	0.000	0.983	0.017
C85.7 Other specified types of non-Hodgkin's lymphoma	0.017	0.983	0.000
C81.7 Other Hodgkin's disease	0.016	0.983	0.000
C45 Mesothelioma	0.000	0.983	0.017
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.016	0.983	0.000
C81.3 Lymphocytic depletion	0.016	0.983	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.016	0.984	0.000
C38 Malignant neoplasm of heart, mediastinum and pleura	0.016	0.984	0.000
C93.1 Chronic monocytic leukaemia	0.016	0.984	0.000
R06.8 Other and unspecified abnormalities of breathing	0.000	0.984	0.016
C92.4 Acute promyelocytic leukaemia	0.016	0.984	0.000
C92.7 Other myeloid leukaemia	0.016	0.984	0.000
N94.2 Vaginismus	0.000	0.984	0.016
C31 Malignant neoplasm of accessory sinuses	0.016	0.984	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.016	0.984	0.000
C45.7 Mesothelioma of other sites	0.000	0.984	0.016
C92.5 Acute myelomonocytic leukaemia	0.016	0.984	0.000
C81.9 Hodgkin's disease, unspecified	0.016	0.984	0.000
C85.1 B-cell lymphoma, unspecified	0.015	0.985	0.000
N94.4 Primary dysmenorrhoea	0.000	0.985	0.015
C85.0 Lymphosarcoma	0.015	0.985	0.000
C95 Leukaemia of unspecified cell type	0.015	0.985	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.015	0.985	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.015	0.985	0.000
C92.3 Myeloid sarcoma	0.015	0.985	0.000
C92.2 Subacute myeloid leukaemia	0.015	0.985	0.000
C92.9 Myeloid leukaemia, unspecified	0.015	0.985	0.000
C82.0 Small cleaved cell, follicular	0.015	0.985	0.000
N94.9 Unspecified condition associated with female genital organs and menstrual cycle	0.000	0.985	0.015
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.014	0.985	0.000
C86.4 Blastic NK-cell lymphoma	0.014	0.985	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.014	0.985	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.014	0.985	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.014	0.985	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.014	0.985	0.000
C93.9 Monocytic leukaemia, unspecified	0.014	0.986	0.000
C93.7 Other monocytic leukaemia	0.014	0.986	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.014	0.986	0.000
C93.2 Subacute monocytic leukaemia	0.014	0.986	0.000
C93.0 Acute monocytic leukaemia	0.014	0.986	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.014	0.986	0.000
C88.7 Other malignant immunoproliferative diseases	0.014	0.986	0.000
C88.3 Immunoproliferative small intestinal disease	0.014	0.986	0.000
C88.2 Gamma heavy chain disease	0.014	0.986	0.000
C88.1 Alpha heavy chain disease	0.014	0.986	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.014	0.986	0.000
C45.0 Mesothelioma of pleura	0.000	0.986	0.014
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs	0.014	0.986	0.000
C33 Malignant neoplasm of trachea	0.014	0.986	0.000
N94.0 Mittelschmerz	0.000	0.986	0.014
C15.9 Oesophagus, unspecified	0.014	0.986	0.000
C30 Malignant neoplasm of nasal cavity and middle ear	0.014	0.986	0.000
C15.5 Lower third of oesophagus	0.014	0.986	0.000
C38.4 Pleura	0.013	0.986	0.000
C82.6 Cutaneous follicle centre lymphoma	0.013	0.986	0.000
C82.5 Diffuse follicle centre lymphoma	0.013	0.986	0.000
C31.0 Maxillary sinus	0.013	0.987	0.000
C94.7 Other specified leukaemias	0.013	0.987	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.013	0.987	0.000
C94.5 Acute myelofibrosis	0.013	0.987	0.000
C94.4 Acute panmyelosis	0.013	0.987	0.000
C94.3 Mast cell leukaemia	0.013	0.987	0.000
C94.2 Acute megakaryoblastic leukaemia	0.013	0.987	0.000
C94.1 Chronic erythraemia	0.013	0.987	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.013	0.987	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.013	0.987	0.000
C96.8 Histiocytic sarcoma	0.013	0.987	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.013	0.987	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.013	0.987	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.013	0.987	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.013	0.987	0.000
C96.3 True histiocytic lymphoma	0.013	0.987	0.000
C96.2 Malignant mast cell tumour	0.013	0.987	0.000
C96.1 Malignant histiocytosis	0.013	0.987	0.000
C96.0 Letterer-Siwe disease	0.013	0.987	0.000
C37 Malignant neoplasm of thymus	0.013	0.987	0.000
C82.4 Follicular lymphoma grade IIIb	0.013	0.987	0.000
N81.6 Rectocele	0.000	0.987	0.013
C38.3 Mediastinum, part unspecified	0.013	0.987	0.000
C15 Malignant neoplasm of oesophagus	0.013	0.987	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.012	0.988	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.012	0.988	0.000
C45.2 Mesothelioma of pericardium	0.000	0.988	0.012
C45.1 Mesothelioma of peritoneum	0.000	0.988	0.012
C82.3 Follicular lymphoma grade IIIa	0.012	0.988	0.000
C38.8 Overlapping lesion of heart, mediastinum and pleura	0.012	0.988	0.000
C38.2 Posterior mediastinum	0.012	0.988	0.000
C38.1 Anterior mediastinum	0.012	0.988	0.000
C38.0 Heart	0.012	0.988	0.000
Z29.0 Isolation	0.012	0.988	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.012	0.988	0.000
C31.9 Accessory sinus, unspecified	0.011	0.988	0.000
C31.8 Overlapping lesion of accessory sinuses	0.011	0.988	0.000
C31.3 Sphenoidal sinus	0.011	0.988	0.000
C31.2 Frontal sinus	0.011	0.988	0.000
C31.1 Ethmoidal sinus	0.011	0.988	0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.000	0.988	0.012
C95.1 Chronic leukaemia of unspecified cell type	0.011	0.988	0.000
Z29.2 Other prophylactic chemotherapy	0.011	0.989	0.000
C82.2 Large cell, follicular	0.011	0.989	0.000
L30.9 Dermatitis, unspecified	0.011	0.989	0.000
C95.7 Other leukaemia of unspecified cell type	0.011	0.989	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.011	0.989	0.000
C95.0 Acute leukaemia of unspecified cell type	0.011	0.989	0.000
Z29 Need for other prophylactic measures	0.011	0.989	0.000
Z29.8 Other specified prophylactic measures	0.011	0.989	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.010	0.989	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.010	0.989	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.010	0.989	0.000
C84.3 Lymphoepithelioid lymphoma	0.010	0.989	0.000
C84.2 T-zone lymphoma	0.010	0.989	0.000
C84.1 Sezary's diease	0.010	0.989	0.000
C49 Malignant neoplasm of other connective and soft tissue	0.000	0.989	0.011
C39.9 Ill-defined sites within the respiratory system	0.010	0.989	0.000
C39.8 Overlapping lesion of respiratory and intrathoracic organs	0.010	0.989	0.000
C39.0 Upper respiratory tract, part unspecified	0.010	0.989	0.000
N94.8 Other specified conditions associated with female genital organs and menstrual cycle	0.000	0.990	0.010
C15.1 Thoracic part of oesophagus	0.010	0.990	0.000
C84.5 Other and unspecified T-cell lymphomas	0.010	0.990	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.010	0.990	0.000
C15.0 Cervical part of oesophagus	0.010	0.990	0.000
C30.1 Middle ear	0.010	0.990	0.000
H40.0 Glaucoma suspect	0.000	0.990	0.010
C84.4 Peripheral T-cell lymphoma	0.010	0.990	0.000
C92.0 Acute myeloid leukaemia	0.010	0.990	0.000
C49.5 Connective and soft tissue of pelvis	0.000	0.990	0.010
L30 Other dermatitis	0.010	0.990	0.000
C83.3 Large cell (diffuse)	0.009	0.991	0.000
C48 Malignant neoplasm of retroperitoneum and peritoneum	0.000	0.991	0.009
C30.0 Nasal cavity	0.009	0.991	0.000
C15.8 Overlapping lesion of oesophagus	0.009	0.991	0.000
C15.2 Abdominal part of oesophagus	0.009	0.991	0.000
L28 Lichen simplex chronicus and prurigo	0.009	0.991	0.000
C15.3 Upper third of oesophagus	0.009	0.991	0.000
C84.0 Mycosis fungoides	0.009	0.991	0.000
L28.1 Prurigo nodularis	0.009	0.991	0.000
C49.9 Connective and soft tissue, unspecified	0.000	0.991	0.009
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system	0.000	0.991	0.008
C46 Kaposi's sarcoma	0.000	0.991	0.008
L28.0 Lichen simplex chronicus	0.008	0.992	0.000
C49.2 Connective and soft tissue of lower limb, including hip	0.000	0.992	0.008
C48.1 Specified parts of peritoneum	0.000	0.992	0.008
L20-L30 Dermatitis and eczema	0.008	0.992	0.000
Z29.9 Prophylactic measure, unspecified	0.008	0.992	0.000
C49.6 Connective and soft tissue of trunk, unspecified	0.000	0.992	0.008
D80.1 Nonfamilial hypogammaglobulinaemia	0.008	0.992	0.000
C49.8 Overlapping lesion of connective and soft tissue	0.000	0.992	0.008
L30.8 Other specified dermatitis	0.008	0.992	0.000
L30.4 Erythema intertrigo	0.008	0.992	0.000
C15.4 Middle third of oesophagus	0.008	0.992	0.000
I69.3 Sequelae of cerebral infarction	0.000	0.992	0.008
L20 Atopic dermatitis	0.008	0.992	0.000
C48.0 Retroperitoneum	0.000	0.992	0.008
C49.0 Connective and soft tissue of head, face and neck	0.000	0.992	0.007
C49.4 Connective and soft tissue of abdomen	0.000	0.993	0.007
C95.9 Leukaemia, unspecified	0.007	0.993	0.001
L30.3 Infective dermatitis	0.007	0.993	0.000
C49.1 Connective and soft tissue of upper limb, including shoulder	0.000	0.993	0.007
D80 Immunodeficiency with predominantly antibody defects	0.007	0.993	0.000
C49.3 Connective and soft tissue of thorax	0.000	0.993	0.007
I69 Sequelae of cerebrovascular disease	0.000	0.993	0.007
L30.5 Pityriasis alba	0.007	0.993	0.000
L30.2 Cutaneous autosensitisation	0.007	0.993	0.000
L30.0 Nummular dermatitis	0.007	0.993	0.000
L20.9 Atopic dermatitis, unspecified	0.007	0.993	0.000
L30.1 Dyshidrosis [pompholyx]	0.007	0.993	0.000
C48.8 Overlapping lesion of retroperitoneum and peritoneum	0.000	0.993	0.007
C32 Malignant neoplasm of larynx	0.007	0.993	0.000
N81.1 Cystocele	0.000	0.993	0.007
L23 Allergic contact dermatitis	0.007	0.993	0.000
L28.2 Other prurigo	0.007	0.993	0.000
D86 Sarcoidosis	0.007	0.993	0.000
Z01.9 Special examination, unspecified	0.000	0.993	0.007
D80-D89 Certain disorders involving the immune mechanism	0.007	0.993	0.000
N81 Female genital prolapse	0.000	0.994	0.006
C46.9 Kaposi's sarcoma, unspecified	0.000	0.994	0.006
C46.8 Kaposi's sarcoma of multiple organs	0.000	0.994	0.006
C46.7 Kaposi's sarcoma of other sites	0.000	0.994	0.006
C46.3 Kaposi's sarcoma of lymph nodes	0.000	0.994	0.006
C46.2 Kaposi's sarcoma of palate	0.000	0.994	0.006
C46.1 Kaposi's sarcoma of soft tissue	0.000	0.994	0.006
C46.0 Kaposi's sarcoma of skin	0.000	0.994	0.006
C47.9 Peripheral nerves and autonomic nervous system, unspecified	0.000	0.994	0.006
C47.8 Overlapping lesion of peripheral nerves and autonomic nervous system	0.000	0.994	0.006
C47.6 Peripheral nerves of trunk, unspecified	0.000	0.994	0.006
C47.5 Peripheral nerves of pelvis	0.000	0.994	0.006
C47.4 Peripheral nerves of abdomen	0.000	0.994	0.006
C47.3 Peripheral nerves of thorax	0.000	0.994	0.006
C47.2 Peripheral nerves of lower limb, including hip	0.000	0.994	0.006
C47.1 Peripheral nerves of upper limb, including shoulder	0.000	0.994	0.006
C47.0 Peripheral nerves of head, face and neck	0.000	0.994	0.006
K61.0 Anal abscess	0.006	0.994	0.000
N81.8 Other female genital prolapse	0.000	0.994	0.006
L25 Unspecified contact dermatitis	0.006	0.994	0.000
N61 Inflammatory disorders of breast	0.006	0.994	0.000
H80-H83 Diseases of inner ear	0.000	0.994	0.006
D80.4 Selective deficiency of immunoglobulin M [IgM]	0.006	0.994	0.000
C91 Lymphoid leukaemia	0.006	0.994	0.000
I69.2 Sequelae of other nontraumatic intracranial haemorrhage	0.000	0.994	0.006
L24 Irritant contact dermatitis	0.006	0.994	0.000
L26 Exfoliative dermatitis	0.006	0.994	0.000
L22 Diaper [napkin] dermatitis	0.006	0.994	0.000
N94.6 Dysmenorrhoea, unspecified	0.000	0.994	0.006
D80.6 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia	0.006	0.994	0.000
D86.3 Sarcoidosis of skin	0.006	0.994	0.000
Z99.3 Dependence on wheelchair	0.000	0.994	0.006
D86.8 Sarcoidosis of other and combined sites	0.006	0.994	0.000
D80.9 Immunodeficiency with predominantly antibody defects, unspecified	0.006	0.994	0.000
L20.8 Other atopic dermatitis	0.006	0.994	0.000
D89 Other disorders involving the immune mechanism, not elsewhere classified	0.006	0.994	0.000
L20.0 Besnier's prurigo	0.006	0.994	0.000
L23.1 Allergic contact dermatitis due to adhesives	0.006	0.994	0.000
L27 Dermatitis due to substances taken internally	0.006	0.994	0.000
D89.2 Hypergammaglobulinaemia, unspecified	0.006	0.994	0.000
D86.9 Sarcoidosis, unspecified	0.006	0.994	0.000
G81.9 Hemiplegia, unspecified	0.000	0.994	0.006
D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses	0.006	0.994	0.000
D80.8 Other immunodeficiencies with predominantly antibody defects	0.005	0.994	0.000
D80.7 Transient hypogammaglobulinaemia of infancy	0.005	0.994	0.000
D80.5 Immunodeficiency with increased immunoglobulin M [IgM]	0.005	0.994	0.000
D80.0 Hereditary hypogammaglobulinaemia	0.005	0.994	0.000
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.005	0.994	0.000
L23.5 Allergic contact dermatitis due to other chemical products	0.005	0.994	0.000
C48.2 Peritoneum, unspecified	0.000	0.995	0.005
D83 Common variable immunodeficiency	0.005	0.995	0.000
C32.8 Overlapping lesion of larynx	0.005	0.995	0.000
C32.3 Laryngeal cartilage	0.005	0.995	0.000
C32.2 Subglottis	0.005	0.995	0.000
C91.5 Adult T-cell leukaemia	0.005	0.995	0.000
L23.8 Allergic contact dermatitis due to other agents	0.005	0.995	0.000
L23.7 Allergic contact dermatitis due to plants, except food	0.005	0.995	0.000
L23.6 Allergic contact dermatitis due to food in contact with the skin	0.005	0.995	0.000
L23.4 Allergic contact dermatitis due to dyes	0.005	0.995	0.000
L23.3 Allergic contact dermatitis due to drugs in contact with the skin	0.005	0.995	0.000
L23.2 Allergic contact dermatitis due to cosmetics	0.005	0.995	0.000
L23.0 Allergic contact dermatitis due to metals	0.005	0.995	0.000
L21 Seborrhoeic dermatitis	0.005	0.995	0.000
L89.1 Stage II decubitus ulcer	0.005	0.995	0.000
N81.9 Female genital prolapse, unspecified	0.000	0.995	0.005
D81 Combined immunodeficiencies	0.005	0.995	0.000
C32.1 Supraglottis	0.005	0.995	0.000
D82 Immunodeficiency associated with other major defects	0.005	0.995	0.000
L27.2 Dermatitis due to ingested food	0.005	0.995	0.000
D86.0 Sarcoidosis of lung	0.005	0.995	0.000
L25.9 Unspecified contact dermatitis, unspecified cause	0.005	0.995	0.000
D84 Other immunodeficiencies	0.005	0.995	0.000
D89.0 Polyclonal hypergammaglobulinaemia	0.005	0.995	0.000
L25.8 Unspecified contact dermatitis due to other agents	0.005	0.995	0.000
L25.5 Unspecified contact dermatitis due to plants, except food	0.005	0.995	0.000
L25.4 Unspecified contact dermatitis due to food in contact with the skin	0.005	0.995	0.000
L25.3 Unspecified contact dermatitis due to other chemical products	0.005	0.995	0.000
L25.2 Unspecified contact dermatitis due to dyes	0.005	0.995	0.000
L25.1 Unspecified contact dermatitis due to drugs in contact with the skin	0.005	0.995	0.000
L25.0 Unspecified contact dermatitis due to cosmetics	0.005	0.995	0.000
L23.9 Allergic contact dermatitis, unspecified cause	0.005	0.995	0.000
H82 Vertiginous syndromes in diseases classified elsewhere	0.000	0.995	0.005
C91.8 Mature B-cell leukaemia Burkitt-type	0.005	0.995	0.000
C91.7 Other lymphoid leukaemia	0.005	0.995	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.005	0.995	0.000
C91.3 Prolymphocytic leukaemia	0.005	0.995	0.000
C91.2 Subacute lymphocytic leukaemia	0.005	0.995	0.000
L24.9 Irritant contact dermatitis, unspecified cause	0.004	0.995	0.000
L24.8 Irritant contact dermatitis due to other agents	0.004	0.995	0.000
L24.7 Irritant contact dermatitis due to plants, except food	0.004	0.995	0.000
L24.6 Irritant contact dermatitis due to food in contact with the skin	0.004	0.995	0.000
L24.5 Irritant contact dermatitis due to other chemical products	0.004	0.995	0.000
L24.4 Irritant contact dermatitis due to drugs in contact with the skin	0.004	0.995	0.000
L24.3 Irritant contact dermatitis due to cosmetics	0.004	0.995	0.000
L24.2 Irritant contact dermatitis due to solvents	0.004	0.995	0.000
L24.1 Irritant contact dermatitis due to oils and greases	0.004	0.995	0.000
L24.0 Irritant contact dermatitis due to detergents	0.004	0.995	0.000
D89.1 Cryoglobulinaemia	0.004	0.995	0.000
D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified	0.004	0.995	0.000
D89.3 Immune reconstitution syndrome	0.004	0.995	0.000
N81.5 Vaginal enterocele	0.000	0.995	0.005
L27.1 Localised skin eruption due to drugs and medicaments	0.004	0.995	0.000
I69.1 Sequelae of intracerebral haemorrhage	0.000	0.996	0.004
Z29.1 Prophylactic immunotherapy	0.004	0.996	0.000
D83.9 Common variable immunodeficiency, unspecified	0.004	0.996	0.000
L27.9 Dermatitis due to unspecified substance taken internally	0.004	0.996	0.000
L27.8 Dermatitis due to other substances taken internally	0.004	0.996	0.000
D80.2 Selective deficiency of immunoglobulin A [IgA]	0.004	0.996	0.000
D86.1 Sarcoidosis of lymph nodes	0.004	0.996	0.000
E04.2 Non-toxic multinodular goitre	0.000	0.996	0.004
M85.65 Other cyst of bone (Pelvic region and thigh)	0.004	0.996	0.000
D84.8 Other specified immunodeficiencies	0.004	0.996	0.000
D83.8 Other common variable immunodeficiencies	0.004	0.996	0.000
D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells	0.004	0.996	0.000
D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders	0.004	0.996	0.000
D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function	0.004	0.996	0.000
N81.2 Incomplete uterovaginal prolapse	0.000	0.996	0.004
Z80.8 Family history of malignant neoplasm of other organs or systems	0.004	0.996	0.000
I69.8 Sequelae of other and unspecified cerebrovascular diseases	0.000	0.996	0.004
L21.8 Other seborrhoeic dermatitis	0.004	0.996	0.000
L21.1 Seborrhoeic infantile dermatitis	0.004	0.996	0.000
L21.0 Seborrhoea capitis	0.004	0.996	0.000
H60.1 Cellulitis of external ear	0.000	0.996	0.004
J36 Peritonsillar abscess	0.004	0.996	0.000
D81.9 Combined immunodeficiency, unspecified	0.004	0.996	0.000
D81.8 Other combined immunodeficiencies	0.004	0.996	0.000
D81.7 Major histocompatibility complex class II deficiency	0.004	0.996	0.000
D81.6 Major histocompatibility complex class I deficiency	0.004	0.996	0.000
D81.5 Purine nucleoside phosphorylase [PNP] deficiency	0.004	0.996	0.000
D81.4 Nezelof's syndrome	0.004	0.996	0.000
D81.3 Adenosine deaminase [ADA] deficiency	0.004	0.996	0.000
D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers	0.004	0.996	0.000
D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers	0.004	0.996	0.000
D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis	0.004	0.996	0.000
I22.8 Subsequent myocardial infarction of other sites	0.000	0.996	0.004
D82.9 Immunodeficiency associated with major defect, unspecified	0.004	0.996	0.000
D82.8 Immunodeficiency associated with other specified major defects	0.004	0.996	0.000
D82.4 Hyperimmunoglobulin E [IgE] syndrome	0.004	0.996	0.000
D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus	0.004	0.996	0.000
D82.2 Immunodeficiency with short-limbed stature	0.004	0.996	0.000
D82.0 Wiskott-Aldrich syndrome	0.004	0.996	0.000
D82.1 Di George's syndrome	0.004	0.996	0.000
D89.9 Disorder involving the immune mechanism, unspecified	0.004	0.996	0.000
D84.0 Lymphocyte function antigen-1 [LFA-1] defect	0.004	0.996	0.000
D84.1 Defects in the complement system	0.004	0.996	0.000
K52.8 Other specified non-infective gastro-enteritis and colitis	0.004	0.996	0.000
M85.6 Other cyst of bone	0.004	0.996	0.000
C91.9 Lymphoid leukaemia, unspecified	0.003	0.996	0.000
C91.4 Hairy-cell leukaemia	0.003	0.996	0.000
C91.0 Acute lymphoblastic leukaemia	0.003	0.996	0.000
F10.3 Withdrawal state	0.000	0.996	0.004
N81.3 Complete uterovaginal prolapse	0.000	0.996	0.004
K61 Abscess of anal and rectal regions	0.004	0.996	0.000
L89 Decubitus ulcer	0.004	0.996	0.000
M85.67 Other cyst of bone (Ankle and foot)	0.003	0.996	0.000
G40.6 Grand mal seizures, unspecified (with or without petit mal)	0.004	0.996	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.003	0.997	0.000
L89.3 Stage IV decubitus ulcer	0.003	0.997	0.000
D84.9 Immunodeficiency, unspecified	0.003	0.997	0.000
L89.0 Stage I decubitus ulcer and pressure area	0.003	0.997	0.000
C32.9 Larynx, unspecified	0.003	0.997	0.001
H80 Otosclerosis	0.000	0.997	0.003
K61.3 Ischiorectal abscess	0.003	0.997	0.000
K55.9 Vascular disorder of intestine, unspecified	0.000	0.997	0.003
M67.2 Synovial hypertrophy, not elsewhere classified	0.000	0.997	0.003
R06.4 Hyperventilation	0.000	0.997	0.003
M67.1 Other contracture of tendon (sheath)	0.000	0.997	0.003
T84.2 Mechanical complication of internal fixation device of other bones	0.003	0.997	0.000
M85.64 Other cyst of bone (Hand)	0.003	0.997	0.000
C78.0 Secondary malignant neoplasm of lung	0.000	0.997	0.003
M85.66 Other cyst of bone (Lower leg)	0.003	0.997	0.000
C32.0 Glottis	0.003	0.997	0.000
H66.3 Other chronic suppurative otitis media	0.000	0.997	0.003
L29 Pruritus	0.003	0.997	0.000
K10.2 Inflammatory conditions of jaws	0.000	0.997	0.003
N41.1 Chronic prostatitis	0.003	0.997	0.000
E24.9 Cushing's syndrome, unspecified	0.000	0.997	0.003
N81.4 Uterovaginal prolapse, unspecified	0.000	0.997	0.003
N81.0 Female urethrocele	0.000	0.997	0.003
K61.1 Rectal abscess	0.003	0.997	0.000
K41.9 Unilateral or unspecified femoral hernia, without obstruction or gangrene	0.000	0.997	0.003
G57.6 Lesion of plantar nerve	0.003	0.997	0.000
M85.69 Other cyst of bone (Site unspecified)	0.003	0.997	0.000
M85.68 Other cyst of bone (Other)	0.003	0.997	0.000
M85.63 Other cyst of bone (Forearm)	0.003	0.997	0.000
M85.62 Other cyst of bone (Upper arm)	0.003	0.997	0.000
M85.61 Other cyst of bone (Shoulder region)	0.003	0.997	0.000
M85.60 Other cyst of bone (Multiple sites)	0.003	0.997	0.000
J94.8 Other specified pleural conditions	0.000	0.997	0.003
L21.9 Seborrhoeic dermatitis, unspecified	0.003	0.997	0.000
K12.1 Other forms of stomatitis	0.003	0.997	0.000
I69.0 Sequelae of subarachnoid haemorrhage	0.000	0.997	0.003
R06 Abnormalities of breathing	0.000	0.997	0.003
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
K61.2 Anorectal abscess	0.003	0.997	0.000
L29.2 Pruritus vulvae	0.003	0.997	0.000
Z36.4 Antenatal screening for foetal growth retardation using ultrasound and other physical methods	0.000	0.997	0.003
M67 Other disorders of synovium and tendon	0.000	0.997	0.003
G81 Hemiplegia	0.000	0.997	0.003
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.003	0.997	0.000
M87.96 Osteonecrosis, unspecified (Lower leg)	0.003	0.997	0.000
M23.89 Other internal derangements of knee (Unspecified ligament or Unspecified meniscus)	0.000	0.997	0.003
M41.90 Scoliosis, unspecified (Multiple sites in spine)	0.003	0.997	0.000
L89.9 Decubitus ulcer and pressure area, unspecified	0.003	0.997	0.000
R06.2 Wheezing	0.000	0.997	0.003
H66.1 Chronic tubotympanic suppurative otitis media	0.000	0.997	0.003
T50.9 Other and unspecified drugs, medicaments and biological substances	0.003	0.997	0.000
H80.8 Other otosclerosis	0.000	0.997	0.002
H80.2 Cochlear otosclerosis	0.000	0.997	0.002
H80.1 Otosclerosis involving oval window, obliterative	0.000	0.997	0.002
H60 Otitis externa	0.000	0.997	0.003
H66 Suppurative and unspecified otitis media	0.000	0.997	0.003
H83 Other diseases of inner ear	0.000	0.997	0.003
M41.96 Scoliosis, unspecified (Lumbar region)	0.003	0.997	0.000
H02.4 Ptosis of eyelid	0.000	0.997	0.003
N87.1 Moderate cervical dysplasia	0.003	0.997	0.000
K61.4 Intrasphincteric abscess	0.002	0.997	0.000
H66.0 Acute suppurative otitis media	0.000	0.997	0.002
M67.0 Short Achilles tendon (acquired)	0.000	0.997	0.002
L29.3 Anogenital pruritus, unspecified	0.002	0.997	0.000
L29.1 Pruritus scroti	0.002	0.997	0.000
M67.8 Other specified disorders of synovium and tendon	0.000	0.997	0.003
H60.8 Other otitis externa	0.000	0.997	0.002
H60.5 Acute otitis externa, non-infective	0.000	0.997	0.002
J61 Pneumoconiosis due to asbestos and other mineral fibres	0.000	0.997	0.002
M87.95 Osteonecrosis, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
L89.2 Stage III decubitus ulcer	0.002	0.998	0.000
L27.0 Generalised skin eruption due to drugs and medicaments	0.002	0.998	0.000
M41.9 Scoliosis, unspecified	0.002	0.998	0.000
L29.8 Other pruritus	0.002	0.998	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.002	0.998	0.000
H60-H62 Diseases of external ear	0.000	0.998	0.002
H61.9 Disorder of external ear, unspecified	0.000	0.998	0.002
H66.4 Suppurative otitis media, unspecified	0.000	0.998	0.002
H80.0 Otosclerosis involving oval window, nonobliterative	0.000	0.998	0.002
R06.7 Sneezing	0.000	0.998	0.002
R06.3 Periodic breathing	0.000	0.998	0.002
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.998	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.998	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.998	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.002	0.998	0.000
T44.0 Anticholinesterase agents	0.002	0.998	0.000
Z36.3 Antenatal screening for malformations using ultrasound and other physical methods	0.000	0.998	0.002
Z36.1 Antenatal screening for raised alphafetoprotein level	0.000	0.998	0.002
M67.9 Disorder of synovium and tendon, unspecified	0.000	0.998	0.002
M67.3 Transient synovitis	0.000	0.998	0.002
G81.0 Flaccid hemiplegia	0.000	0.998	0.002
S49.9 Unspecified injury of shoulder and upper arm	0.000	0.998	0.002
G57 Mononeuropathies of lower limb	0.002	0.998	0.000
M41.95 Scoliosis, unspecified (Thoracolumbar region)	0.002	0.998	0.000
E87.0 Hyperosmolality and hypernatraemia	0.002	0.998	0.000
H60.4 Cholesteatoma of external ear	0.000	0.998	0.002
M87.9 Osteonecrosis, unspecified	0.002	0.998	0.000
Z20-Z29 Persons with potential health hazards related to communicable diseases	0.002	0.998	0.000
Chapter VIII Diseases of the ear and mastoid process	0.000	0.998	0.002
H66.2 Chronic atticoantral suppurative otitis media	0.000	0.998	0.002
H83.8 Other specified diseases of inner ear	0.000	0.998	0.002
H83.2 Labyrinthine dysfunction	0.000	0.998	0.002
H83.1 Labyrinthine fistula	0.000	0.998	0.002
H83.3 Noise effects on inner ear	0.000	0.998	0.002
G57.3 Lesion of lateral popliteal nerve	0.002	0.998	0.000
M85 Other disorders of bone density and structure	0.002	0.998	0.000
G57.8 Other mononeuropathies of lower limb	0.002	0.998	0.000
M41.92 Scoliosis, unspecified (Cervical region)	0.002	0.998	0.000
G57.5 Tarsal tunnel syndrome	0.002	0.998	0.000
G81.1 Spastic hemiplegia	0.000	0.998	0.002
T47.2 Stimulant laxatives	0.002	0.998	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.002	0.998	0.000
D35.2 Pituitary gland	0.000	0.998	0.002
T47.1 Other antacids and anti-gastric-secretion drugs	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations